Skip to navigation Skip to content

Treatments of CIS


An MS disease-modifying therapy (DMT) is often recommended for people diagnosed with CIS that is considered likely to progress to clinically definite MS (CDMS), with the goal of delaying a second attack. There are DMTs approved by the US Food and Drug and Administration (FDA) for relapsing forms of MS, which includes CIS.

Early and ongoing treatment with disease-modifying therapy is supported by the MS Coalition which includes the National MS Society. This evidence-based Consensus on Disease-Modifying Therapies (.pdf) may be useful when discussing treatment options with your healthcare provider and advocating with insurers for access and coverage.


Your input is important!

We believe that people affected by MS live better lives when they're connected.  To help us provide you with the best resources, support and information, please provide your feedback in a short survey.
Take the survey